FDA Finalizes Guidance on Mandatory Cosmetics Recalls: What Importers and Manufacturers Need to Know

On October 23, 2026, the U.S. Food and Drug Administration (FDA) published a notice announcing the availability of its final guidance, Questions and Answers Regarding Mandatory Cosmetics Recalls: Guidance for Industry. The guidance explains how FDA intends to exercise its mandatory recall authority under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).

The guidance addresses when FDA may order a mandatory recall, the procedures the agency must follow, and what companies can expect if a recall is ordered. It finalizes a December 2025 draft without substantive changes.

For cosmetics importers, manufacturers, distributors, and brand owners, the guidance reinforces the importance of having procedures in place to identify potentially unsafe products, respond to FDA communications, and manage recalls when necessary.

Key Takeaways

• FDA Clarifies Mandatory Recall Authority: The final guidance explains how FDA may require the recall of certain adulterated or misbranded cosmetic products that present a serious health risk.
• Voluntary Recalls Remain the First Step: FDA generally must provide the responsible person an opportunity to voluntarily recall the affected product before ordering a mandatory recall.
• Importers and Manufacturers Should Review Recall Procedures: Businesses should evaluate product traceability, supplier communications, distribution records, and recall response plans.
• No New Recall Authority Created: The authority comes from MoCRA, enacted in 2022. The final guidance explains FDA’s implementation of that existing authority.
• Guidance Finalized Without Substantive Changes: Following public comments on the December 2025 draft, FDA issued the final version without substantive revisions.

When Can FDA Order a Mandatory Cosmetics Recall?

Under Section 611 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. § 364g, FDA’s mandatory recall authority applies when the agency determines that there is a reasonable probability that a cosmetic is adulterated or misbranded and that use of or exposure to the product will cause serious adverse health consequences or death.

This means that not every labeling violation, product defect, or compliance issue automatically triggers a mandatory recall. The statute establishes a specific threshold involving both the product’s regulatory status and the seriousness of the potential health consequences.

The new guidance is intended to help businesses understand how FDA evaluates these circumstances and implements its statutory authority.

How Does the Mandatory Recall Process Work?

The statute establishes several steps before FDA can require a mandatory recall.

1. Opportunity for voluntary action

When FDA makes the necessary determination, it must first provide the responsible person with an opportunity to voluntarily stop distributing and recall the affected cosmetic.

2. Order to cease distribution

If the responsible person refuses or fails to take the requested voluntary action, FDA may issue an order requiring distribution of the product to cease immediately.

3. Opportunity for a hearing

The responsible person must be given an opportunity for an informal hearing within 10 days after the order is issued. The hearing addresses whether sufficient evidence supports the agency’s action.

4. Final agency action

Following the applicable process, FDA may vacate the order, continue the distribution restriction, or amend the order to require a recall. A mandatory recall order may include notification requirements, a recall timetable, and periodic progress reports.

The statute also provides for public notifications and notices to affected parties, including manufacturers, distributors, importers, and retailers.

What Does This Mean for Cosmetics Importers?

Although the mandatory recall provisions primarily address the responsible person identified under MoCRA, the consequences of a recall can extend throughout the supply chain.

Importers may face significant operational challenges when imported cosmetic products become subject to a recall, particularly when inventory has already been distributed to warehouses, retailers, or consumers.

Businesses importing cosmetics into the United States should consider several compliance measures:

• Maintain product traceability: Keep accurate records identifying manufacturers, suppliers, product lots, shipments, and downstream distribution.
• Establish recall procedures: Develop a documented process for identifying affected merchandise, suspending distribution, communicating with business partners, and coordinating product recovery.
• Review supplier agreements: Clarify which party is responsible for regulatory notifications, recall expenses, product retrieval, and other corrective actions.
• Monitor product safety concerns: Establish procedures for escalating consumer complaints, adverse events, and information suggesting that a product may be adulterated or misbranded.
• Coordinate FDA and customs compliance: Evaluate the implications of recalls for imported inventory, including merchandise awaiting distribution or potentially affected by separate FDA import enforcement actions.

These measures can help companies respond more efficiently to FDA inquiries and reduce disruption when a product safety issue arises.

Does the Guidance Create New Requirements?

The October 2026 guidance does not create new mandatory recall authority. It explains FDA’s interpretation and intended implementation of authority established by MoCRA in 2022.

FDA received seven public comments on its December 2025 draft guidance. After reviewing those comments, the agency finalized the guidance without substantive changes.

The document is also nonbinding guidance, meaning it reflects FDA’s current thinking rather than creating independently enforceable legal obligations. Businesses may use alternative approaches that satisfy applicable statutory and regulatory requirements.

What Should Businesses Do Now?

Cosmetics importers, manufacturers, distributors, and brand owners should review their existing recall procedures in light of the final guidance.

In particular, companies should understand who qualifies as the responsible person under MoCRA, how potential safety concerns are escalated, and whether their existing distribution records would allow them to identify and locate affected products promptly.

Businesses should also evaluate their contractual relationships with foreign suppliers and domestic distributors to ensure responsibilities are clearly allocated if FDA requests a voluntary recall or issues a mandatory order.

The guidance underscores the importance of proactive compliance planning. While voluntary recalls remain an important mechanism for addressing unsafe cosmetics, companies should be prepared for situations in which FDA exercises its mandatory recall authority.

Diaz Trade Law will continue monitoring FDA regulatory developments affecting cosmetics importers and businesses operating in international trade.

This article is provided for general informational purposes and does not constitute legal advice.